Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group.
BMJ. 1998 Sep 12;317(7160):703-13.
PMID:9732337
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
Sykora D, Firth C, Girardo M, Tseng A, Wennberg P, Liedl D, Shamoun F.
Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease.
Gazzaruso C, Montalcini T, Gallotti P, Ferrulli A, Massa Saluzzo C, Pujia A, Luzi L, Coppola A.
Endocrine. 2023 Apr;80(1):71-78. doi: 10.1007/s12020-022-03291-6. Epub 2022 Dec 24.
PMID:36565405
Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial.
Caruso P, Maiorino MI, Longo M, Maio A, Scappaticcio L, Di Martino N, Carbone C, Barrasso M, Caputo M, Gicchino M, Bellastella G, Giugliano D, Esposito K.